Literature DB >> 2466390

Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by beta protein immunostain.

H Yamaguchi1, S Hirai, M Morimatsu, M Shoji, Y Nakazato.   

Abstract

We studied senile plaques (SP) in the cerebella of six autopsied subjects with Alzheimer-type dementia (ATD) and ten non-ATD autopsied subjects between the ages of 78 and 90. Neither SP nor amyloid angiopathy (AA) was observed in any of the non-ATD subjects. In the four of the six ATD subjects, diffuse plaques in the molecular layer were seen as ill-defined areas of fine fibrillar materials by beta protein immunostaining with formic acid pretreatment, the modified Bielschowsky stain, and periodic acid-methenamine silver (PAM) stain. The plaques were not visible with Bodian, Congo red, or periodic acid-Schiff stains. Compact plaques in the Purkinje cell or in the granular cell layers were found in three of the six subjects. Their amyloid core was often surrounded by areolar amyloid deposits. AA was observed in three of the six subjects. The argyrophilia of the diffuse and compact plaques, demonstrated by the modified Bielschowsky and PAM stains, became undetectable when the sections were first treated with formic acid. Such treatment made the plaques immunoreactive with beta protein antiserum. The findings suggested that cerebellar diffuse plaques and compact plaques consist mainly of an amyloid component, and are characteristic of ATD.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2466390     DOI: 10.1007/bf00687584

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  12 in total

1.  A comparative study of modified Bielschowsky, Bodian and thioflavin S stains on Alzheimer's neurofibrillary tangles.

Authors:  T Yamamoto; A Hirano
Journal:  Neuropathol Appl Neurobiol       Date:  1986 Jan-Feb       Impact factor: 8.090

2.  Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids.

Authors:  T Kitamoto; K Ogomori; J Tateishi; S B Prusiner
Journal:  Lab Invest       Date:  1987-08       Impact factor: 5.662

3.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

4.  Primary idiopathic cerebrovascular amyloidosis in a child.

Authors:  C M Shaw
Journal:  Brain       Date:  1979-03       Impact factor: 13.501

5.  A variety of cerebral amyloid deposits in the brains of the Alzheimer-type dementia demonstrated by beta protein immunostaining.

Authors:  H Yamaguchi; S Hirai; M Morimatsu; M Shoji; Y Ihara
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

6.  Presenile Alzheimer disease: amyloid plaques in the cerebellum.

Authors:  J D Pro; C H Smith; S M Sumi
Journal:  Neurology       Date:  1980-08       Impact factor: 9.910

7.  Monoclonal antibodies raised against a subsequence of senile plaque core protein react with plaque cores, plaque periphery and cerebrovascular amyloid in Alzheimer's disease.

Authors:  D Allsop; M Landon; M Kidd; J S Lowe; G P Reynolds; A Gardner
Journal:  Neurosci Lett       Date:  1986-07-24       Impact factor: 3.046

8.  Neuritic plaques and cerebrovascular amyloid in Alzheimer disease are antigenically related.

Authors:  C W Wong; V Quaranta; G G Glenner
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

9.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

10.  Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

Authors:  C L Masters; G Multhaup; G Simms; J Pottgiesser; R N Martins; K Beyreuther
Journal:  EMBO J       Date:  1985-11       Impact factor: 11.598

View more
  45 in total

1.  Senile plaques, amyloid beta-protein, and acetylcholinesterase fibres: laminar distributions in Alzheimer's disease striate cortex.

Authors:  T G Beach; E G McGeer
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  A case of progressive supranuclear palsy with widespread senile plaques.

Authors:  S Sasaki; S Maruyama; C Toyoda
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

3.  Quantitative analysis of [18F]FDDNP PET using subcortical white matter as reference region.

Authors:  Koon-Pong Wong; Mirwais Wardak; Weber Shao; Magnus Dahlbom; Vladimir Kepe; Jie Liu; Nagichettiar Satyamurthy; Gary W Small; Jorge R Barrio; Sung-Cheng Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-10-31       Impact factor: 9.236

4.  Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET.

Authors:  Rik Ossenkoppele; Nelleke Tolboom; Jessica C Foster-Dingley; Sofie F Adriaanse; Ronald Boellaard; Maqsood Yaqub; Albert D Windhorst; Frederik Barkhof; Adriaan A Lammertsma; Philip Scheltens; Wiesje M van der Flier; Bart N M van Berckel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-03-23       Impact factor: 9.236

5.  Amyloid and its association with default network integrity in Alzheimer's disease.

Authors:  Sofie M Adriaanse; Ernesto J Sanz-Arigita; Maja A A Binnewijzend; Rik Ossenkoppele; Nelleke Tolboom; Daniëlle M E van Assema; Alle Meije Wink; Ronald Boellaard; Maqsood Yaqub; Albert D Windhorst; Wiesje M van der Flier; Philip Scheltens; Adriaan A Lammertsma; Serge A R B Rombouts; Frederik Barkhof; Bart N M van Berckel
Journal:  Hum Brain Mapp       Date:  2012-12-14       Impact factor: 5.038

6.  Perfusion-like template and standardized normalization-based brain image analysis using 18F-florbetapir (AV-45/Amyvid) PET.

Authors:  Ing-Tsung Hsiao; Chin-Chang Huang; Chia-Ju Hsieh; Shiaw-Pyng Wey; Mei-Ping Kung; Tzu-Chen Yen; Kun-Ju Lin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-15       Impact factor: 9.236

7.  Comparability of [18F]THK5317 and [11C]PIB blood flow proxy images with [18F]FDG positron emission tomography in Alzheimer's disease.

Authors:  Elena Rodriguez-Vieitez; Antoine Leuzy; Konstantinos Chiotis; Laure Saint-Aubert; Anders Wall; Agneta Nordberg
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

Review 8.  Amyloid imaging of Alzheimer's disease using Pittsburgh Compound B.

Authors:  Keith A Johnson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

9.  Test-retest variability of quantitative [11C]PIB studies in Alzheimer's disease.

Authors:  Nelleke Tolboom; Maqsood Yaqub; Ronald Boellaard; Gert Luurtsema; Albert D Windhorst; Philip Scheltens; Adriaan A Lammertsma; Bart N M van Berckel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-04-22       Impact factor: 9.236

10.  PrP in pathology and pathogenesis in scrapie-infected mice.

Authors:  M E Bruce; P A McBride; M Jeffrey; J R Scott
Journal:  Mol Neurobiol       Date:  1994 Apr-Jun       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.